AUSTIN, Texas (GenomeWeb) – A research team from the Sidney Kimmel Cancer Center at Johns Hopkins University is collaborating with Cepheid to adapt a cell-free methylated DNA assay for early diagnosis and monitoring of breast cancer to a cartridge format that could run on Cepheid's GeneXpert system.

Sara Sukumar, who is spearheading the Hopkins team, discussed the effort at a corporate-sponsored workshop at the Association for Molecular Pathology annual meeting held here this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.